Virtue Capital Management LLC Purchases 13,922 Shares of iShares Biotechnology ETF $IBB

Virtue Capital Management LLC acquired a new position in shares of iShares Biotechnology ETF (NASDAQ:IBB) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 13,922 shares of the financial services provider’s stock, valued at approximately $2,931,000.

Other large investors have also made changes to their positions in the company. Pension & Wealth Management Advisors Inc. bought a new stake in shares of iShares Biotechnology ETF in the second quarter valued at about $28,000. Bell Investment Advisors Inc bought a new position in iShares Biotechnology ETF during the third quarter valued at about $29,000. Trust Co. of Vermont bought a new position in iShares Biotechnology ETF during the second quarter valued at about $44,000. GKV Capital Management Co. Inc. bought a new position in iShares Biotechnology ETF during the first quarter valued at about $49,000. Finally, Compass Financial Management LLC acquired a new position in iShares Biotechnology ETF in the 2nd quarter valued at approximately $56,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

iShares Biotechnology ETF stock opened at $217.61 on Monday. The business has a 50 day moving average price of $208.43 and a two-hundred day moving average price of $184.81. iShares Biotechnology ETF has a 12 month low of $154.62 and a 12 month high of $222.29.

iShares Biotechnology ETF Cuts Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, September 18th. Stockholders of record on Tuesday, September 15th were given a dividend of $0.0112 per share. This is a drop from iShares Biotechnology ETF’s previous quarterly dividend of $0.0238. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.0%. The ex-dividend date was Tuesday, September 15th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.